Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 10, Issue 2-4, Pages 153-160

Cytomegalovirus Infection Modulates Cellular Immunity in an Experimental Model for Autoimmune Diabetes

1Faculty of Medical Sciences, Department of Cell Biology, Immunology Section, University of Groningen, A. Deusinglaan 1, Groningen, AV 9713, The Netherlands
2Department of Medical Microbiology, University Hospital Maastricht, P.O. Box 5800, Maastricht, AZ 6202, The Netherlands

Copyright © 2003 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Jan-Luuk Hillebrands, Joanne G. Dam, Geanina Onuta, Flip A. Klatter, Gert Grauls, Cathrien A. Bruggeman, and Jan Rozing, “Cytomegalovirus-enhanced development of transplant arteriosclerosis in the rat; effect of timing of infection and recipient responsiveness,” Transplant International, vol. 18, no. 6, pp. 735–742, 2005. View at Publisher · View at Google Scholar
  • Nienke van der Werf, Frans G.M. Kroese, Jan Rozing, and Jan-Luuk Hillebrands, “Viral infections as potential triggers of type 1 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 23, no. 3, pp. 169–183, 2007. View at Publisher · View at Google Scholar
  • Martin Joseph Richer, and Marc Steven Horwitz, “Viral infections in the pathogenesis of autoimmune diseases: Focus on type 1 diabetes,” Frontiers in Bioscience, vol. 13, no. 11, pp. 4241–4257, 2008. View at Publisher · View at Google Scholar
  • Elad Goldberg, and Ilan Krause, “Infection and type 1 diabetes mellitus - A two edged sword?,” Autoimmunity Reviews, vol. 8, no. 8, pp. 682–686, 2009. View at Publisher · View at Google Scholar
  • Danny Zipris, “Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms,” Clinical Immunology, vol. 131, no. 1, pp. 11–23, 2009. View at Publisher · View at Google Scholar
  • Rebecka Holmberg, William Klitz, Martin Blixt, Per-Olof Berggren, Lisa Juntti-Berggren, and Bo Niklasson, “Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats,” Microbiology and Immunology, vol. 53, no. 10, pp. 567–572, 2009. View at Publisher · View at Google Scholar
  • F. M. Egro, “Why is type 1 diabetes increasing?,” Journal of Molecular Endocrinology, vol. 51, no. 1, pp. R1–R13, 2013. View at Publisher · View at Google Scholar
  • Maria E Craig, Sandhya Nair, Hayley Stein, and William D Rawlinson, “Viruses and type 1 diabetes: a new look at an old story,” Pediatric Diabetes, 2013. View at Publisher · View at Google Scholar
  • Angelico Mendy, Janvier Gasana, Edgar R. Vieira, and Hamidou Diallo, “Prospective study of cytomegalovirus seropositivity and risk of mortality from diabetes,” Acta Diabetologica, 2014. View at Publisher · View at Google Scholar